SCHEMBL10185674

SCHEMBL10185674

O=C1C(N(C(=O)CN2CCOCC2)c2cccc(F)c2)c2ccccc2N1C1CCCCC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDH1 O75874 4/20 0.48
▸ OPRM1 P35372 3/20 0.38
▸ OPRK1 P41145 2/20 0.38
▸ OPRL1 P41146 2/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ HTR1A P08908 1/20 0.37
▸ DRD2 P14416 1/20 0.37
▸ HTR2A P28223 1/20 0.37
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ TDP2 O95551 1/20 0.35
▸ CASP6 P55212 1/20 0.35
▸ UBE2I P63279 1/20 0.35
▸ HKDC1 Q2TB90 1/20 0.35
▸ SAE1 Q9UBE0 1/20 0.35
▸ UBA2 Q9UBT2 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ CCKAR P32238 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10183330 0.90 IDH1 (0.48) IDH1OPRM1OPRK1OPRL1ALDH1A1
SCHEMBL10184102 0.88 IDH1 (0.37) IDH1OPRM1OPRK1OPRL1LMNA
SCHEMBL10185708 0.86 LMNA (0.41) IDH1OPRM1OPRK1OPRL1ALDH1A1
SCHEMBL10183324 0.86 IDH1 (0.37) IDH1OPRM1OPRK1OPRL1ALDH1A1
SCHEMBL10183299 0.86 OPRM1 (0.40) IDH1OPRM1OPRK1OPRL1LMNA
SCHEMBL10183756 0.85 TSHR (0.44) IDH1OPRM1OPRK1OPRL1ALDH1A1
SCHEMBL10183337 0.85 OPRM1 (0.39) IDH1OPRM1OPRK1OPRL1LMNA
SCHEMBL10183319 0.85 MEN1 (0.43) IDH1OPRM1OPRK1OPRL1ALDH1A1
SCHEMBL10185657 0.83 IDH1 (0.47) IDH1OPRM1OPRK1OPRL1ALDH1A1
SCHEMBL10183782 0.82 OPRM1 (0.40) IDH1OPRM1OPRK1OPRL1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012009678-A1 THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHOD OF USE AGIOS PHARMACEUTICALS, INC. (US) 2012-01-19 — — WO disclosed
Send feedback